503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
19.74%
Some net income increase while ORCL is negative at -42.78%. John Neff would see a short-term edge over the struggling competitor.
-3.34%
Both reduce yoy D&A, with ORCL at -0.57%. Martin Whitman would suspect a lull in expansions or intangible additions for both.
69.36%
Well above ORCL's 89.93% if it’s a large positive yoy. Michael Burry would see a bigger future tax burden vs. competitor’s approach.
9.54%
SBC growth well above ORCL's 3.17%. Michael Burry would flag major dilution risk vs. competitor’s approach.
-89.91%
Negative yoy working capital usage while ORCL is 344.01%. Joel Greenblatt would see more free cash if revenue remains unaffected, giving a short-term advantage.
188.66%
AR growth well above ORCL's 114.38%. Michael Burry would fear inflated sales or less stringent credit controls vs. competitor.
16.13%
Some inventory rise while ORCL is negative at -80.00%. John Neff would see competitor possibly benefiting from leaner stock if demand remains.
-13233.33%
Both negative yoy AP, with ORCL at -286.31%. Martin Whitman would find an overall trend toward paying down supplier credit in the niche.
-100.26%
Both reduce yoy usage, with ORCL at -95.51%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
96.19%
Some yoy increase while ORCL is negative at -67.74%. John Neff would see competitor possibly reining in intangible charges or revaluations more effectively than we do.
46.22%
Operating cash flow growth at 75-90% of ORCL's 52.01%. Bill Ackman would recommend further refinements to match competitor’s CFO gains.
25.59%
Some CapEx rise while ORCL is negative at -71.01%. John Neff would see competitor possibly building capacity while we hold back expansions.
-396.73%
Both yoy lines negative, with ORCL at -2033.33%. Martin Whitman sees an overall caution or integration phase for both companies’ expansions.
-77.70%
Both yoy lines negative, with ORCL at -68.47%. Martin Whitman would suspect an environment with fewer attractive securities or a strategic pivot to internal growth.
30.63%
Proceeds from sales/maturities above 1.5x ORCL's 14.27%. David Dodd would confirm if the firm is capitalizing on strong valuations or freeing liquidity for expansions.
148.40%
Growth of 148.40% while ORCL is zero at 0.00%. Bruce Berkowitz sees a moderate difference requiring justification by ROI in these smaller invests.
-20.34%
Both yoy lines negative, with ORCL at -612.00%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
-26.79%
We cut debt repayment yoy while ORCL is 52.77%. Joel Greenblatt sees competitor possibly lowering risk more if expansions do not hamper them.
112.45%
We slightly raise equity while ORCL is negative at -37.87%. John Neff sees competitor possibly preserving share count or buying back shares.
-14.59%
We cut yoy buybacks while ORCL is 1.97%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.